2056
India’s Cipla Signs Contract
Economy, Business And Markets

India’s Cipla Signs Contract

Mumbai-based pharmaceutical company Cipla has announced that it has signed a new contract with its existing distributor to produce generic drugs in Iran. The Indian firm’s investment of $37 million in a new production plant would see the company hold a 75 percent stake in the proposed unit. Cipla has said it will also offer new drug manufacturing equipment in addition to its technical know-how. Recently the company announced it acquired a 60 percent stake in an unnamed Sri Lankan-based company for $14 million, which would market its products in that country. It also acquired 51 percent stake in a UAE-based pharmaceutical company which has manufacturing and distribution business in Yemen for $21 million.

 

Short URL : http://goo.gl/04r7pD

You can also read ...

Central Bank of Iran Against Market Intervention
Central Bank of Iran's Governor Abdolnasser Hemmati said the...
New Forex Initiative Unable to Tip Scales
The new forex initiative has only managed to fix major policy...
VDMA Backs Iran Trade
Germany’s plastics and rubber machinery trade association,...
Equity-Based Sukuk Return to Iran Capital Market
The government is set to clear part of its debt to Social...
Musk Bid for Tesla Still Murky
Tesla Inc’s board named a special committee of three directors...
Tehran Shows 4th Biggest Upturn in Economist’s Livability Index
Tehran is one of the top five cities in the world to have...
Over €81m Worth of Airport Equipment Purchased  Post JCPOA
Iran Airports & Air Navigation Company, an arm of the...
S. Korea Bans Recalled BMWs Over Fire Fears
The South Korean government has said it will ban about 20,000...

Trending

Googleplus